跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
AFQLIR 40 MG/ML SOLUCION INYECTABLE EN VIAL
Approved
STANDARD
AFQLIR 40 MG/ML SOLUCION INYECTABLE EN VIAL
Sandoz Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 22, 2024
Approval ID
17a79a3c9f888c3e
Company
Sandoz Gmbh
Type
Standard
Approval Details
Approval Id
17a79a3c9f888c3e
Drug Cima Aemps Name
AFQLIR 40 MG/ML SOLUCION INYECTABLE EN VIAL
Register Number
1241867002
Holder Company Name
Sandoz Gmbh
Marketing Company Name
Sandoz Farmaceutica S.A.
Holder Company Detail Path
/organization/sandoz-gmbh
Authorization Date
2024-11-22
Dosage Form
SOLUCIÓN INYECTABLE
Dose
40 mg/ml
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Sandoz Gmbh
Company Detail Path
/organization/sandoz-gmbh
Company Information
Pharmaceutical Company Name
Sandoz Gmbh
Country Name
Costa Rica
Website
http://www.sandoz.at
Active Ingredients
AFLIBERCEPT
40 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 22, 2024
Approval ID
17a79a3c9f888c3e
Type
Standard
Back to CIMA-AEMPS Approvals
AFQLIR 40 MG/ML SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details
